How do I subscribe to ongoing alerts?

Subscribe to /feed/company/pa-stwowy-instytut-medyczny-ministerstwa-spraw-wewn-trznych-i-administracji.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Rifaximin (drug)	Rifaximin (drug)	marketed	Rifamycin antibiotic	Bacterial RNA polymerase	Gastroenterology / Infectious Disease

Therapeutic area mix

Gastroenterology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bausch Health Americas, Inc. · 1 shared drug class
Institute of Tropical Medicine, Belgium · 1 shared drug class
Miguel Santín · 1 shared drug class
National Institute of Allergy and Infectious Diseases (NIAID) · 1 shared drug class
National Taiwan University Hospital · 1 shared drug class
Seoul National University Hospital · 1 shared drug class
South China Children's Leukemia Group · 1 shared drug class
Suzhou Zelgen Biopharmaceuticals Co.,Ltd · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji:

Cite this brief

Drug Landscape (2026). Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/pa-stwowy-instytut-medyczny-ministerstwa-spraw-wewn-trznych-i-administracji. Accessed 2026-05-17.